The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease
Open accessAbstract
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) damages the nigrostriatal dopaminergic pathway as seen in Parkinson's disease (PD), a common neurodegenerative disorder with no effective protective treatment. Consistent with a role of glial cells in PD neurodegeneration, here we show that minocycline, an approved tetracycline derivative that inhibits microglial activation independently of its antimicrobial properties, mitigates both the demise of nigrostriatal dopaminergic neurons and the formation of nitrotyrosine produced by MPTP. In addition, we show that minocycline not only prevents MPTP-induced activation of microglia but also the formation of mature interleukin-1beta and the activation of NADPH-oxidase and inducible nitric oxide synthase (iNOS), three key microglial-derived cytotoxic mediators. Previously, we demonstrated that ablation of iNOS attenuates MPTP-induced neurotoxicity. Now, we demonstrate that iNOS is not the only microglial-related culprit implicated in MPTP-induced toxicity because mutant iNOS-deficient mice treated with minocycline are more resistant to this neurotoxin than iNOS-deficient mice not treated with minocycline. This study demonstrates that microglial-related inflammatory events play a significant role in the MPTP neurotoxic process and suggests that minocycline may be a valuable neuroprotective agent for the treatment of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect is mainly ascribable to the minocycline-dependent suppression of microglia activation, which has been reported by several in vivo studies [251,258,259,260,261,262,263].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
In the citing paper
“In this respect, microglial inactivation by minocycline correlates with decreased IL-1β formation, as well as reduced NADPH-oxidase and inducible nitric oxide synthase (iNOS) activity, suggesting that both anti-inflammatory and antioxidant pathways are involved [262,264].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
In the citing paper
“In this respect, microglial inactivation by minocycline correlates with decreased IL-1β formation, as well as reduced NADPH-oxidase and inducible nitric oxide synthase (iNOS) activity, suggesting that both anti-inflammatory and antioxidant pathways are involved [262,264].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
In the citing paper
“In this respect, microglial inactivation by minocycline correlates with decreased IL-1β formation, as well as reduced NADPH-oxidase and inducible nitric oxide synthase (iNOS) activity, suggesting that both anti-inflammatory and antioxidant pathways are involved [262,264].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Free Radicals in Biology and Medicine
Land, E. J. (1990) · International Journal of Radiation Biology · doi:10.1080/09553009014552071 · Cited by 4,871
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Microglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,111
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 19×
“…decreases MPTP-mediated nitrotyrosine formation A significant part of the MPTP neurotoxic process is mediated by NO-related oxidative damage (Przedborski et al., 2000), the extent of which can be evaluated by assessing nitrotyrosine levels (Liberatore et al., 1999; Pennathur et al., 1999).”
BackgroundMethodResultInfluentialYrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040
Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,032
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Research works printed but not linked: 1
- Fahn S, Przedborski S (2000) Parkinsonism. In: Merritt's neurology (Rowland LP, ed), pp 679 -693. New York: Lippincott Williams & Wilkins.
Cited by
Sorted by citations
Items 601–700 of 999
MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats.
Wang, W., Wu, S., Liou, Y., Wang, A., Pawlak, C. R., & Ho, Y. (2009) · Behavioral Neuroscience · doi:10.1037/a0017401 · Cited by 54
Kato, H., Kurosaki, R., Oki, C., & Araki, T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.046 · Cited by 54
Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice
Rojo, A. I., Montero, C., Salazar‐Roa, M., Close, R. M., Fernández‐Ruíz, J., Sánchez-González, M. Á., de Sagarra, M. R., Jackson-Lewis, V. R., Cavada, C., & Cuadrado, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05060.x · Cited by 54
Min, K., Jang, J., & Kwon, T. K. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00943.x · Cited by 53
Epigallocatechin-3-Gallate, a Promising Molecule for Parkinson's Disease?
Renaud, J., Nabavi, S. F., Daglia, M., Nabavi, S. M., & Martinoli, M. (2015) · Rejuvenation Research · doi:10.1089/rej.2014.1639 · Cited by 53
The executioners sing a new song: killer caspases activate microglia
Venero, J. L., Burguillos, M. Á., Brundin, P., & Joseph, B. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.107 · Cited by 55
Machado, A., Herrera, A. J., Venero, J. L., Santiago, M., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Argüelles, S., Sarmiento, M., Delgado‐Cortés, M. J., et al. (2011) · Parkinson s Disease · doi:10.4061/2011/393769 · Cited by 54
Choong, C., Sasaki, T., Hayakawa, H., Yasuda, T., Baba, K., Hirata, Y., Uesato, S., & Mochizuki, H. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.001 · Cited by 54
Li, T., Fan, H. J., & Wang, Y. (2016) · Journal of Pain · doi:10.1016/j.jpain.2015.12.015 · Cited by 53
Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives
Minchev, D. S., Kazakova, M., & Sarafian, V. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314997 · Cited by 55
Minocycline Alleviates Sevoflurane-Induced Cognitive Impairment in Aged Rats
Tian, Y., Guo, S., Wu, X., Ma, L., & Zhao, X. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0154-6 · Cited by 53
Stress-induced microglial activation may facilitate the progression of neurodegenerative disorders
Sugama, S. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.02.047 · Cited by 52
Minocycline in phenotypic models of Huntington's disease
Bantubungi, K., Jacquard, C., Greco, A., Pintor, A., Chtarto, A., Taï, K., Galas, M., Tenenbaum, L., Déglon, N., Popoli, P., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.017 · Cited by 53
Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice
Yokoyama, H., Takagi, S., Watanabe, Y., Kato, H., & Araki, T. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0019-6 · Cited by 52
Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice
Crocker, S. J., Liston, P., Anisman, H., Lee, C. J., Smith, P. D., Earl, N., Thompson, C. S., Park, D. S., Korneluk, R. G., & Robertson, G. S. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00020-7 · Cited by 52
Virgone‐Carlotta, A., Uhlrich, J., Akram, M. N., Ressnikoff, D., Chrétien, F., Domenget, C., Gherardi, R. K., Despars, G., Jurdic, P., Honnorat, J., et al. (2013) · Glia · doi:10.1002/glia.22546 · Cited by 52
Iravani, M. M., Sadeghian, M., Leung, C. C. M., Jenner, P. G., & Rose, S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.01.022 · Cited by 53
Wright, J. W., Kawas, L. H., & Harding, J. W. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.11.004 · Cited by 51
Ito, N., Obata, H., & Saito, S. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181b05f42 · Cited by 51
Kalonia, H., Mishra, J., & Kumar, A. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9315-x · Cited by 51
Hamill, C. E., Caudle, W. M., Richardson, J. R., Yuan, H., Pennell, K. D., Greene, J. G., Miller, G. W., & Traynelis, S. F. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038158 · Cited by 52
Avagliano, C., Russo, R., Caro, C. D., Cristiano, C., Rana, G. L., Piegari, G., Paciello, O., Citraro, R., Russo, E., Sarro, G. D., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.004 · Cited by 50
Li, T.-F., Gong, N., & Wang, Y. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00367 · Cited by 51
NADPH Oxidase and the Degeneration of Dopaminergic Neurons in Parkinsonian Mice
Hernandes, M. S., Café-Mendes, C. C., & Britto, L. R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/157857 · Cited by 51
Abbaszadeh, A., Darabi, S., Hasanvand, A., Amini-Khoei, H., Abbasnezhad, A., Choghakhori, R., & Aaliehpour, A. (2018) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.24248.6053 · Cited by 50
Xue, X., Zhang, W., Zhu, J., Chen, X., Zhou, S., Xu, Z., Hu, G., & Su, C. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14147 · Cited by 50
Godoy, M. C. P., Ferrari, C. C., & Pitossi, F. J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.02.018 · Cited by 50
Ohgidani, M., Kato, T. A., & Kanba, S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00184 · Cited by 52
Choi, D., Lee, M. K., & Hong, J. T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.001 · Cited by 49
BONDY, S., & Sharman, E. H. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.12.014 · Cited by 49
Massri, N. E., Johnstone, D. M., Peoples, C. L., Moro, C., Reinhart, F., Torres-Martinez, N., Stone, J., Benabid, A., & Mitrofanis, J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.994063 · Cited by 48
Williams, C. J., & Dexter, D. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12608 · Cited by 48
Pinna, A., Tronci, E., Schintu, N., Simola, N., Volpini, R., Pontis, S., Cristalli, G., & Morelli, M. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.012 · Cited by 48
Hassanzadeh, K., Habibiasl, B., Farajnia, S., & Roshangar, L. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9212-0 · Cited by 48
Binukumar, B. K., Shukla, V., Amin, N. D., Grant, P. G., Bhaskar, M., Skuntz, S., Steiner, J. P., & Pant, H. C. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-06-0415 · Cited by 48
Vodret, S., Bortolussi, G., Iaconcig, A., Elena, M., Tiribelli, C., & Muro, A. F. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.02.011 · Cited by 48
The unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
Cresto, N., Gardier, C., Gubinelli, F., Gaillard, M., Liot, G., West Andrew, B., & Brouillet, E. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14182 · Cited by 49
Rani, L., & Mondal, A. C. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.01.001 · Cited by 48
Shibata, H., Katsuki, H., Nishiwaki, M., Kume, T., Kaneko, S., & Akaike, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01929.x · Cited by 48
APOEgenotype-dependent modulation of astrocyte chemokine CCL3 production
Cudaback, E., Yang, Y. J., Montine, T. J., & Keene, C. D. (2014) · Glia · doi:10.1002/glia.22732 · Cited by 47
Silibinin Attenuates MPP + -Induced Neurotoxicity in the Substantia Nigra In Vivo
Jung, U. J., Jeon, M., Choi, M., & Kim, S. R. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.2926 · Cited by 47
Machado, A., Herrera, A. J., Venero, J. L., Santiago, M., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Argüelles, S., Sarmiento, M., Delgado‐Cortés, M. J., et al. (2011) · ISRN Neurology · doi:10.5402/2011/476158 · Cited by 47
The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III
Vojdani, A., Lambert, J., & Kellermann, G. H. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep064 · Cited by 47
Martin, H. L., Mounsey, R. B., Sathe, K., Mustafa, S., Nelson, M. C., Evans, R. M., & Teismann, P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.058 · Cited by 49
McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.09.061 · Cited by 47
Liu, M., Cai, T., Zhao, F., Zheng, G., Wang, Q., Chen, Y., Huang, C., Luo, W., & Chen, J. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9045-x · Cited by 46
Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration
Budge, K. M., Neal, M. P., Richardson, J. R., & Safadi, F. F. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01921-6 · Cited by 46
Si, X., Fang, Y., Li, L., Gu, L., Yin, X., Jun-Tian, Yan, Y., Pu, J., & Zhang, B. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113525 · Cited by 46
Cao, X., Arai, H., Ren, Y., Oizumi, H., Zhang, N., Seike, S., Furuya, T., Yasuda, T., Mizuno, Y., & Mochizuki, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04125.x · Cited by 46
Carbon Monoxide Pathophysiology and Treatment
Thom, S. R. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3406-3.50020-2 · Cited by 45
Profile of minocycline and its potential in the treatment of schizophrenia
Zhang, L., & Zhao, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s64236 · Cited by 45
Activin as an anti-inflammatory cytokine produced by microglia
Sugama, S., Takenouchi, T., Kitani, H., Fujita, M., & Hashimoto, M. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.08.016 · Cited by 45
Iuvone, T., Esposito, G., Filippis, D. D., Bisogno, T., Petrosino, S., Scuderi, C., Marzo, V. D., & Steardo, L. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0233-y · Cited by 45
Kim, C., Ojo-Amaize, E., Spencer, B., Rockenstein, E., Mante, M., Desplats, P., Wrasidlo, W., Adame, A., Nchekwube, E., Oyemade, O., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0455-9 · Cited by 45
Cunha, M. P., Pazini, F. L., Lieberknecht, V., Budni, J., Oliveira‐Giacomelli, Á., Rosa, J. M., Mancini, G., Mazzardo‐Martins, L., Colla, A. R. D. S., Leite, M. C., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0147-1 · Cited by 45
Infiltration of circulating myeloid cells through CD95L contributes to neurodegeneration in mice
Gao, L., Brenner, D., Llorens-Bobadilla, E., Saiz-Castro, G., Frank, T., Wieghofer, P., Hill, O., Thiemann, M., Karray, S., Prinz, M., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20132423 · Cited by 42
Buskila, Y., Abu‐Ghanem, Y., Levi, Y., Moran, A., Grauer, E., & Amitai, Y. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000843 · Cited by 44
Philippens, I. H. C. H. M., Wubben, J. A. M., Finsen, B. R., & Hart, B. A. ‘. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9450-z · Cited by 44
Jose, S., Tan, S. W., Ooi, Y. Y., Ramasamy, R., & Vidyadaran, S. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0149-8 · Cited by 44
Yoshioka, Y., Sugino, Y., Shibagaki, F., Yamamuro, A., Ishimaru, Y., & Maeda, S. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172826 · Cited by 45
Inhibitory modulation of the mitochondrial permeability transition by minocycline
Gieseler, A., Schultze, A. T., Kupsch, K., Haroon, M. F., Wolf, G. L., Siemen, D., & Kreutzmann, P. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.003 · Cited by 44
Inflammation in Parkinson's disease
Wüllner, U., & Klockgether, T. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1107-x · Cited by 45
Pradhan, S., & Andreasson, K. I. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.008 · Cited by 43
Kim, S. R., Chung, E. S., Bok, E., Baik, H. H., Chung, Y. C., Won, S. Y., Joe, E., Kim, T. H., Kim, S. S., Jin, M. Y., et al. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22318 · Cited by 43
Rahmani, M., Negro, S., & Barcia, E. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106237 · Cited by 43
Ortíz, G. G., Pacheco-Moisés, F. P., Gómez-Rodríguez, V. M., González-Renovato, E. D., Torres-Sánchez, E. D., & Anguiano, A. C. R. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9416-0 · Cited by 43
Seoposengwe, K., van Tonder, J. J., & Steenkamp, V. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-353 · Cited by 43
Gao, J., Sun, S., Li, W., Chen, Y., & Cai, D. (2008) · Neuroscience Bulletin · doi:10.1007/s12264-008-1225-9 · Cited by 43
Thomas, D. M., Francescutti, D. M., & Kuhn, D. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05421.x · Cited by 43
Orío, L., Llopis, N., Torres, E., Izco, M., O’Shea, E., & Colado, M. I. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9120-3 · Cited by 42
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
Belloli, S., Morari, M., Murtaj, V., Valtorta, S., Moresco, R. M., & Gilardi, M. C. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00152 · Cited by 43
Role of Extracellular Factors in Axon Regeneration in the CNS: Implications for Therapy
Gervasi, N. M., Kwok, J. C. F., & Fawcett, J. W. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.6.907 · Cited by 42
Tripanichkul, W., & Jaroensuppaperch, E.-O. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.648760 · Cited by 42
The innate and adaptive immunological aspects in neurodegenerative diseases
Rodrigues, M. C. O., Sanberg, P. R., Cruz, L. E. G., & Garbuzova-Davis, S. N. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.020 · Cited by 42
MAZZIO, E. A., Close, F. T., & Soliman, K. F. A. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12010506 · Cited by 41
Sawada, H., Hishida, R., Hirata, Y., Ono, K., Suzuki, H., Muramatsu, S., Nakano, I., Nagatsu, T., & Sawada, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21241 · Cited by 40
Nuclear Receptors, Inflammation, and Neurodegenerative Diseases
Saijo, K., Crotti, A., & Glass, C. K. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)06002-5 · Cited by 42
Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation.
Yang, L., Zhu, X. A., & Tso, M. O. M. (2007) · PubMed Central · Cited by 41
Ji, A.-L., Diao, H., Wang, X., Yang, R., Zhang, J., Luo, W., Cao, R., Cao, Z., Wang, F., & Cai, T. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.02.018 · Cited by 44
Aminov, R. I. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00241 · Cited by 40
Zhang, D., Hu, X., Wei, S., Liu, J., Gao, H., Li, Q., Wilson, B. C., Liu, G.-T., & Hong, J. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-21 · Cited by 40
Rahmat, Z., Jose, S., Ramasamy, R., & Vidyadaran, S. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt160 · Cited by 40
Neuroprotective effects of exogenous methane in a rat model of acute carbon monoxide poisoning
Fan, D.-F., Hu, H., Sun, Q., Lv, Y., Ye, Z.-H., Sun, X., & Pan, S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.12.019 · Cited by 40
Herman, F. J., Westfall, S., Brathwaite, J. S., & Pasinetti, G. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00867 · Cited by 43
Kosloski, L. M., Ha, D. M., Hutter-Saunders, J. A. L., Stone, D. K., Pichler, M. R., Reynolds, A. D., Gendelman, H. E., & Mosley, R. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06834.x · Cited by 40
Scheller, D., Chan, P., Li, Q., Wu, T., Zhang, R., Guan, L., Ravenscroft, P., Guigoni, C., Crossman, A. R., Hill, M. P., et al. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.026 · Cited by 40
Moldoveanu, C.-A., Tomoaia-Cotişel, M., Sevastre-Berghian, A., Tomoaia-Cotişel, M., Mocanu, A., Pal-Racz, C., Toma, V. A., Roman, I., Ujica, M. A., & Pop, L. C. (2024) · Molecules · doi:10.3390/molecules30010043 · Cited by 39
Bastos, L. F. S., de Oliveira, A. C. P., Watkins, L. R., Moraes, M. F. D., & Coelho, M. M. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0727-1 · Cited by 41
Expression Profiling of Genes Modulated by Minocycline in a Rat Model of Neuropathic Pain
Rojewska, E., Korostyński, M., Przewłocki, R., Przewłocka, B., & Mika, J. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-47 · Cited by 40
Towards translational therapies for multiple system atrophy
Kuzdas-Wood, D., Stefanova, N., Jellinger, K. A., Seppi, K., Schlossmacher, M. G., Poewe, W. H., & Wenning, G. K. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.007 · Cited by 39
Sheu, J., Wang, K.-H., Lin, H., & Huang, C. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.12.961 · Cited by 39
Medical Management of Parkinsons Disease: Focus on Neuroprotection
Rı́os, C., Boll, M., & Alcaraz-Zubeldia, M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596577 · Cited by 39
Sulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases
Miller, O. G., & Mieyal, J. J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1496-7 · Cited by 40
Réus, G. Z., Abelaira, H. M., Maciel, A. L., dos Santos, M. A. B., Carlessi, A. S., Steckert, A. V., Ferreira, G. K., Prá, S. D.-T. D., STRECK, E. L., Macêdo, D. S., et al. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9602-8 · Cited by 39
Park, E., & Chun, H. S. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2122-7 · Cited by 39
Shoaib, R. M., Zhang, J., Mao, X.-F., & Wang, Y. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.014 · Cited by 38
Safety and feasibility of minocycline in treatment of acute traumatic brain injury
Meythaler, J. M., Fath, J. J., Fuerst, D. R., Zokary, H., Freese, K., Martin, H. B., Reineke, J., Peduzzi-Nelson, J. D., & Roskos, P. T. (2019) · Brain Injury · doi:10.1080/02699052.2019.1566968 · Cited by 39
Mao, X.-F., Wu, H., Tang, X.-Q., Ali, U., Liu, H., & Wang, Y. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1457-9 · Cited by 40
Shen, Y., Dai, L., Tian, H., Xu, R., Li, F., Li, Z., Zhou, J., Wang, L., Dong, J., & Sun, L. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s230688 · Cited by 39
Carregosa, D., Mota, S., Ferreira, S., Alves-Dias, B., Lončarević‐Vasiljković, N., Crespo, C. L., Menezes, R., Teodoro, R. O., & dos Santos, C. N. (2021) · Nutrients · doi:10.3390/nu13092940 · Cited by 38
Metadata
- Authors
- Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S.
- Affiliations
- Pediatrics and Genetics (US)
- Children's Hospital of Philadelphia (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-03-01
- Volume
- 22
- Issue
- 5
- Pages
- 1763-1771
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6758858
- OpenAlex
- W2148726772
- Cited by
- 1,183
- References
- 44
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 13 · 2023: 15 · 2022: 27 · 2021: 41 · 2020: 27 · 2019: 40 · 2018: 47 · 2017: 42 · 2016: 43 · 2015: 43 · 2014: 68 · 2013: 69 · 2012: 63
- FWCI
- 45.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- Parkinson's Disease Foundation (NS38370)
- Muscular Dystrophy Association
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (5r29ns037345-05, NS38370)
- National Institute on Aging (R01-AG13966, R01AG013966)
- National Institute of Neurological Disorders and Stroke (P50-NS38370, R01 NS 38586, R01 NS 42269, R29 NS37345, R01NS042269, R01NS038586, P50NS038370)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, microglial activation, minocycline, MPTP-induced neurotoxicity, neuroprotection, nitrotyrosine, IL-1β, NADPH oxidase, inducible nitric oxide synthase, nigrostriatal dopaminergic neurons, neuroinflammation, iNOS-deficient mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Astrocytes, Corpus Striatum, Disease Models, Animal, Dose-Response Relationship, Drug, Interleukin-1, Mice, Inbred C57BL, Minocycline, Neurons, Substantia Nigra, Tyrosine, Tyrosine 3-Monooxygenase, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Up-Regulation, Microglia, Mice, Knockout, Neuroprotective Agents, Nitric Oxide Synthase, NADPH Oxidases, Parkinsonian Disorders, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
